SCSIO OpenIR  > 中科院边缘海地质重点实验室
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections
Zhang, LX; Yan, KZ; Zhang, Y; Huang, R; Bian, J; Zheng, CS; Sun, HX; Chen, ZH; Sun, N; An, R; Min, FG; Zhao, WB; Zhuo, Y; You, JL; Song, YJ; Yu, ZY; Liu, ZH; Yang, KQ; Gao, H; Dai, HQ; Zhang, XL; Wang, J; Fu, CZ; Pei, G; Liu, JT; Zhang, S; Goodfellow, M; Jiang, YY; Kuai, J; Zhou, GC; Chen, XP; zhanglixin@im.ac.cn
2007
发表期刊PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN0027-8424
卷号104期号:11页码:4606-4611
摘要The high mortality rate of immunocompromised patients with fungal infections and the limited availability of highly efficacious and safe agents demand the development of new antifungal therapeutics. To rapidly discover such agents, we developed a high-throughput synergy screening (HTSS) strategy for novel microbial natural products. Specifically, a microbial natural product library was screened for hits that synergize the effect of a low dosage of ketoconazole (KTC) that alone shows little detectable fungicidal activity. Through screening of approximate to 20,000 microbial extracts, 12 hits were identified with broadspectrum antifungal activity. Seven of them showed little cytotoxicity against human hepatoma cells. Fractionation of the active extracts revealed beauvericin (BEA) as the most potent component, because it dramatically synergized KTC activity against diverse fungal pathogens by a checkerboard assay. Significantly, in our immunocompromised mouse model, combinations of BEA (0.5 mg/kg) and KTC (0.5 mg/kg) prolonged survival of the host infected with Candida parapsilosis and reduced fungal colony counts in animal organs including kidneys, lungs, and brains. Such an effect was not achieved even with the high dose of 50 mg/kg KTC. These data support synergism between BEA and KTC and thereby a prospective strategy for antifungal therapy.
部门归属Chinese Acad Sci, Inst Microbiol, Beijing 100080, Peoples R China; Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Beijing 510663, Peoples R China; Chinese Acad Sci, S China Sea Inst Oceanol, Beijing 510301, Peoples R China; SynerZ Pharmaceut Inc, Lexington, MA 02421 USA; Guangdong Lab Anim Mo0nitoring Inst, Beijing 510301, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China; Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Second Mil Med Univ, Dept Pharmacol, Cambridge, MA 02140 USA; Wyeth Res, Cambridge, MA 02140 USA
关键词Antifungal Beauvericin Ketoconazole
学科领域Multidisciplinary Sciences
URL查看原文
收录类别sci
资助项目海洋地质
WOS记录号WOS:000244972700065
引用统计
被引频次:130[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.scsio.ac.cn/handle/344004/4504
专题中科院边缘海地质重点实验室
通讯作者zhanglixin@im.ac.cn
推荐引用方式
GB/T 7714
Zhang, LX,Yan, KZ,Zhang, Y,et al. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,2007,104(11):4606-4611.
APA Zhang, LX.,Yan, KZ.,Zhang, Y.,Huang, R.,Bian, J.,...&zhanglixin@im.ac.cn.(2007).High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,104(11),4606-4611.
MLA Zhang, LX,et al."High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections".PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 104.11(2007):4606-4611.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
High-throughput syne(514KB) 开放获取--请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。